Bharat Biotech, the manufacturer of Covaxin, has submitted its phase-3 clinical trial to the Central Drug Standards Control Organisation, claiming nearly 78% efficacy of its Covid-19 vaccine, which is currently being used for mass vaccination in India. An expert panel under the CDSCO on Tuesday reviewed the data, news agencies claimed quoting unnamed sources, but … Continue reading Latest Vaccine updates on covaxin covishield and Pfizer in India